Guatemala’s Ministry of Health (MSPAS) gives babies hepatitis B and BCG at birth, then the hexavalent vaccine at 2, 4, 6 and 18 months, and varicella (chickenpox) at 15 months and again from 4 years to under 5. The hexavalent replaced the pentavalent and injectable polio (IPV) vaccines when MSPAS introduced it on 4 November 2025.

In short: The schedule below is the MSPAS list as published by Guatemala’s state news agency AGN on 21 May 2026. Two recent changes: the six-in-one hexavalent vaccine took over from pentavalent plus IPV, and varicella joined the public schedule. For families moving between the two countries, the MSPAS list published by AGN does not include hepatitis A, which the US CDC schedule gives as a 2-dose series. This page is information to take to your paediatrician, not medical advice.

The schedule by age

AGN printed this list ahead of the XXIV Vaccination Week of the Americas (24 to 30 May 2026), run by MSPAS with the Pan American Health Organization (PAHO), and introduced it as the vaccines that would be given that week, those contained in the complete schedule. Ages and dose labels are as AGN prints them.

Age (as printed)VaccineProtects against
At birthHepatitis B (one dose)Hepatitis B and liver complications
At birthBCGMiliary and meningeal tuberculosis
2 months (first dose)HexavalentDiphtheria, tetanus, pertussis, hepatitis B, polio, Haemophilus influenzae type b
2 months (first dose)Pneumococcal (neumococo)Pneumonia, otitis, meningitis
2 months (first dose)RotavirusSevere rotavirus gastroenteritis
4 months (second dose)Hexavalent, pneumococcal, rotavirusAs above
6 months (first dose)Seasonal influenzaSeasonal influenza and its complications
6 monthsHexavalent, third doseAs above
7 months (second dose)Seasonal influenzaAs above
12 months (first dose)SPR (measles, mumps, rubella)Measles, mumps, rubella
12 months (first dose)PneumococcalAs above
15 months (first dose)VaricellaChickenpox
18 months (first booster)Seasonal influenzaAs above
18 months (first booster)Hexavalent + OPVDiphtheria, tetanus, pertussis, hepatitis B, polio
2 years to under 3 (second booster)Seasonal influenzaAs above
4 years to under 5 (second booster)OPVPolio
4 years to under 5 (second booster)DTPDiphtheria, tetanus, pertussis
4 years to under 5 (second booster)VaricellaChickenpox
9 years (single dose)HPV (VPH)Human papillomavirus; girls aged 9 born from 2006 onward, and boys aged 9
10 years (third booster)Tdap R3Tetanus, diphtheria, pertussis

Source: MSPAS schedule as published by AGN, 21 May 2026; protection descriptions as AGN prints them, with the hexavalent’s six diseases as PAHO lists them. The influenza rows are seasonal influenza doses, as AGN labels them.

The same AGN list gives the doses for pregnant women: Td (two doses), Tdap (one dose in each pregnancy), influenza, hepatitis B (three doses) and COVID-19 (a single dose).

Announcing that May 2026 vaccination week, acting health minister Donato Camey said MSPAS would give a measles dosis cero (zero dose) nationally to children aged 6 to 11 months, as part of the push against the measles outbreak in the region. Our measles in Guatemala page follows that outbreak.

What changed: hexavalent, varicella and a new regulation

Hexavalent in, pentavalent and IPV out. PAHO/WHO reports that on 4 November 2025 MSPAS, with PAHO technical support, presented the introduction of the hexavalent vaccine into the national immunization schedule. PAHO lists the six diseases it covers: diphtheria, tetanus, pertussis, polio, hepatitis B and Haemophilus influenzae type b. In a question-and-answer piece published by AGN, Sandy Cano, head of MSPAS’s Departamento de Programas Específicos, set out the rules:

  • It is given at 2, 4, 6 and 18 months, four doses in total, as part of the regular childhood schedule.
  • It replaces the pentavalent vaccine and the injectable polio vaccine (IPV).
  • Some health areas will finish schedules already started with pentavalent plus IPV, because some still hold those doses. Children starting their schedule begin directly with hexavalent.
  • MSPAS says there is no contraindication to a child who received pentavalent and IPV going on to hexavalent, because it protects against the same diseases.
  • A schedule already completed with pentavalent and IPV does not need to be repeated, according to MSPAS. Hexavalent is used only to continue or start schedules.

MSPAS bought more than 600,000 hexavalent doses for Q9.9 million through PAHO’s Revolving Fund, according to the ministry’s post quoted by AGN. If your child’s record mixes pentavalent and hexavalent doses, ask your paediatrician how it reads.

Varicella added to the public schedule. In a report datelined 11 November, AGN wrote that MSPAS introduced the varicella vaccine into the regular immunization schedule, where before it was available only in the private sector and through social security. Health minister Joaquín Barnoya said the 500,000 doses were bought through a PAHO mechanism; MSPAS put the investment at more than Q70 million. The 21 May 2026 list above shows varicella at 15 months and at 4 years to under 5.

A vaccination regulation. The Reglamento de Vacunación, issued as Acuerdo Gubernativo 210-2025, came into force on 26 November after publication in the Diario de Centro América, AGN reported. It implements the Ley de Vacunación (Decreto 25-2024) in 45 articles. Among its contents AGN lists the national vaccination schedule, the publication of the vaccination plan, a Consejo Nacional de Prácticas de Inmunizaciones, a mandatory Sistema Único de Información, and the issuing of vaccination certificates (constancias de vacunación) by the Programa de Inmunizaciones. Its stated principles include voluntariness, free provision (gratuidad) and universality.

What the US schedule lists that the MSPAS list does not

The current US reference is CDC’s Child and Adolescent Immunization Schedule by Age, Addendum updated July 2, 2025. CDC states on that page that, pursuant to the preliminary order issued on 16 March 2026 in American Academy of Pediatrics et al. v. Kennedy et al. (No. 1:25-cv-11916, D. Mass.), which stayed all votes taken by ACIP at its June, September and December 2025 meetings and stayed the Acting CDC Director’s 5 January 2026 Decision Memo revising the childhood schedule, the 2 July 2025 schedule posted there is the current CDC schedule for healthcare professionals.

Set beside that CDC table:

  • Hepatitis A. CDC lists a 2-dose hepatitis A series. The MSPAS list published by AGN does not include hepatitis A.
  • RSV antibody. CDC lists nirsevimab (RSV-mAb) in its infant table. The MSPAS list published by AGN does not include it.
  • Meningococcal vaccines. CDC has rows for MenACWY and MenB. The MSPAS list published by AGN does not include them.
  • A second MMR dose. The CDC table prints a 2nd MMR dose. The MSPAS list published by AGN shows SPR (MMR) at 12 months only.
  • The other direction. The CDC table has no BCG row and no OPV row; its polio row is inactivated poliovirus (IPV). The MSPAS list gives both.

Both schedules give hepatitis B, rotavirus, pneumococcal, influenza, varicella, HPV and Tdap, and the diphtheria-tetanus-pertussis, Hib and polio protection that the hexavalent combines in one shot. Dose counts and ages differ in several rows, and CDC asks providers to read its table together with its notes. A paediatrician on either side is the person to compare a record against the local schedule; for US school-entry rules, ask the school or state, since this page does not cover them.

For the shots CDC recommends for children visiting Guatemala, see our Guatemala with kids guide. For entry requirements, see vaccines required for Guatemala. The pertussis picture, including the 2025 rise in cases, is on our whooping cough page.

This page is general information, not medical advice.

Sources

Frequently Asked Questions

My US-born child is moving to Guatemala: which shots does Guatemala give, and when?

The MSPAS schedule published by the state news agency AGN on 21 May 2026 gives hepatitis B and BCG at birth; hexavalent, pneumococcal and rotavirus vaccines at 2 and 4 months; hexavalent and seasonal influenza at 6 months; MMR (SPR) and pneumococcal at 12 months; varicella at 15 months; hexavalent plus OPV at 18 months; OPV, DTP and varicella from 4 years to under 5; HPV at 9 years; and a Tdap booster at 10 years.

What is the hexavalent vaccine, and when did it replace the pentavalent?

It is a single vaccine against diphtheria, tetanus, pertussis, polio, hepatitis B and Haemophilus influenzae type b. MSPAS, with PAHO/WHO, presented its introduction into the national schedule on 4 November 2025. MSPAS says it replaces the pentavalent vaccine and the injectable polio vaccine (IPV) and is given at 2, 4, 6 and 18 months, four doses in total.

My child started on pentavalent and IPV. What happens now?

MSPAS told AGN that some health areas will finish schedules already started with pentavalent plus IPV, that new schedules start with hexavalent, and that a schedule already completed with pentavalent and IPV does not need to be repeated. Ask your paediatrician how this applies to your child’s record.

Does Guatemala's public schedule include chickenpox (varicella)?

Yes. AGN reported that MSPAS added the varicella vaccine to the regular schedule with 500,000 doses bought through PAHO; before that it was available only in the private sector and through social security. The May 2026 list shows varicella at 15 months and again at 4 years to under 5.

What will a US paediatrician see as missing from a Guatemalan record?

The CDC schedule has rows that the MSPAS list published by AGN does not include, among them a 2-dose hepatitis A series, nirsevimab (listed as RSV-mAb) and the meningococcal vaccines. The CDC table also prints a second MMR dose, while the MSPAS list shows SPR at 12 months. Take both records to your paediatrician.

Which US childhood schedule is current?

CDC states that, under a preliminary court order of 16 March 2026 in American Academy of Pediatrics et al. v. Kennedy et al., its 2 July 2025 schedule is the current CDC Child and Adolescent Immunization Schedule by Age. The order stayed ACIP votes from June, September and December 2025 and a 5 January 2026 CDC decision memo.